MN
MNZO.US Manzo Pharmaceut
- Market cap
- USD 1.00M
- P/E
- -
- P/B
- -
- ROE
- -8.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2016.
Is MNZO.US undervalued?
Graham numberThe Graham number of Manzo Pharmaceut cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Manzo Pharmaceut fundamental analysis
No fundamental analysis for Manzo Pharmaceut yet.
Manzo Pharmaceut stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Manzo Pharmaceut
ExxSun Corporation focuses on clean energy infrastructure investment and residential and commercial real estate development, integrating localized renewable energy systems. The company is involved in developing an integrated Energy-as-a-Service (EaaS) platform, combining solar roofs, solar flowers, wind turbines, and 50 kW battery storage solutions into localized microgrids; and providing solar roof installation services alongside the development of high-demand, energy-effic…
Full company profileManzo Pharmaceut financial statements
2016 annualized: Fiscal year 2016 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2016, the balance sheet is the latest quarter. Figures change when the annual report is published.
Manzo Pharmaceut annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2002 | 2003 | 2004 | 2013 | 2014 | 2015 | 2016 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 2.03M | 3.00M | 3.07M | 0.00 | 183.00 | 2.01K | 9.30K |
| Gross Profit | -725K | 756K | 21.0K | 0.00 | 183.00 | 793.00 | 8.99K |
| Operating Income | -5.36M | -3.25M | -3.20M | -21.7K | -21.7K | -36.2K | -18.0K |
| Net Income | -6.87M | -3.95M | -4.15M | 0.00 | -21.7K | -36.2K | -18.0K |
| Balance Sheet | |||||||
| Total Assets | - | 8.10M | 4.43M | 180K | 187K | 192K | 196K |
| Total Liabilities | - | 26.6M | 26.9M | 310K | 190K | 11.1K | -8.41K |
| Shareholders' Equity | - | -18.5M | -22.5M | -130K | -3.32K | 181K | 204K |
| Cash & Short-term Investments | - | 0.00 | 0.00 | - | 6.71K | 12.3K | 15.5K |
| Cash Flow | |||||||
| Operating Cash Flow | -918K | -1.58M | -1.11M | 22.1K | 22.1K | 276K | -18.0K |
| Capital Expenditure | 2.81M | 3.10K | 2.26K | 0.00 | 0.00 | 0.00 | 0.00 |
| Ratios | |||||||
| ROE | - | - | - | - | - | -20.0% | -8.8% |
| ROA | - | -48.8% | -93.8% | 0.0% | -11.6% | -18.8% | -9.2% |
| Net Profit Margin | -339.2% | -131.6% | -135.2% | - | -11,876.5% | -1,799.6% | -193.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Manzo Pharmaceut dividends
Manzo Pharmaceut has not paid dividends in the last 6 fiscal years.
Last stock split: 1:10 on Sep 17, 2014.
Who owns Manzo Pharmaceut
Ownership data of Manzo Pharmaceut is not available yet.
Manzo Pharmaceut company profile
- Company name
- Manzo Pharmaceut
- Ticker
- MNZO.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Capital Markets
- Employees
- 12
- Fiscal year end
- December
- Address
- 9100 Wilshire Blvd., Beverly Hills, CA, United States, 90212
- Phone
- 707 770 5099
- Website
- exxsun.com
About Manzo Pharmaceut
ExxSun Corporation focuses on clean energy infrastructure investment and residential and commercial real estate development, integrating localized renewable energy systems. The company is involved in developing an integrated Energy-as-a-Service (EaaS) platform, combining solar roofs, solar flowers, wind turbines, and 50 kW battery storage solutions into localized microgrids; and providing solar roof installation services alongside the development of high-demand, energy-efficient single- and multi-family housing and commercial complexes. It was formerly known as Manzo Pharmaceuticals, Inc. and changed its name to ExxSun Corporation in November 2026. ExxSun Corporation was incorporated in 1980 and is based in Beverly Hills, California.
Manzo Pharmaceut management
1- Mr. Kenneth ManzoChairman and Chief Executive Officer